GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00602498 | Cervix | CC | anatomical structure homeostasis | 63/2311 | 314/18723 | 6.03e-05 | 8.68e-04 | 63 |
GO:00722341 | Cervix | CC | metanephric nephron tubule development | 7/2311 | 18/18723 | 3.99e-03 | 2.48e-02 | 7 |
GO:0150063 | Cervix | CC | visual system development | 63/2311 | 375/18723 | 6.58e-03 | 3.65e-02 | 63 |
GO:0001654 | Cervix | CC | eye development | 62/2311 | 371/18723 | 7.83e-03 | 4.13e-02 | 62 |
GO:0048880 | Cervix | CC | sensory system development | 63/2311 | 381/18723 | 9.29e-03 | 4.66e-02 | 63 |
GO:0072170 | Cervix | CC | metanephric tubule development | 7/2311 | 21/18723 | 1.04e-02 | 4.97e-02 | 7 |
GO:0072243 | Cervix | CC | metanephric nephron epithelium development | 7/2311 | 21/18723 | 1.04e-02 | 4.97e-02 | 7 |
GO:0010821 | Colorectum | AD | regulation of mitochondrion organization | 57/3918 | 144/18723 | 2.43e-07 | 9.92e-06 | 57 |
GO:0009636 | Colorectum | AD | response to toxic substance | 88/3918 | 262/18723 | 1.12e-06 | 3.72e-05 | 88 |
GO:0043087 | Colorectum | AD | regulation of GTPase activity | 110/3918 | 348/18723 | 1.64e-06 | 5.03e-05 | 110 |
GO:0007265 | Colorectum | AD | Ras protein signal transduction | 104/3918 | 337/18723 | 1.01e-05 | 2.35e-04 | 104 |
GO:0010822 | Colorectum | AD | positive regulation of mitochondrion organization | 32/3918 | 74/18723 | 1.22e-05 | 2.68e-04 | 32 |
GO:0051056 | Colorectum | AD | regulation of small GTPase mediated signal transduction | 94/3918 | 302/18723 | 1.81e-05 | 3.76e-04 | 94 |
GO:0098754 | Colorectum | AD | detoxification | 53/3918 | 152/18723 | 4.63e-05 | 7.98e-04 | 53 |
GO:0043547 | Colorectum | AD | positive regulation of GTPase activity | 75/3918 | 255/18723 | 7.95e-04 | 7.91e-03 | 75 |
GO:0046578 | Colorectum | AD | regulation of Ras protein signal transduction | 56/3918 | 189/18723 | 2.85e-03 | 2.14e-02 | 56 |
GO:0007266 | Colorectum | AD | Rho protein signal transduction | 42/3918 | 137/18723 | 4.64e-03 | 3.16e-02 | 42 |
GO:00510562 | Colorectum | FAP | regulation of small GTPase mediated signal transduction | 78/2622 | 302/18723 | 3.25e-08 | 2.85e-06 | 78 |
GO:00430873 | Colorectum | FAP | regulation of GTPase activity | 85/2622 | 348/18723 | 1.20e-07 | 7.68e-06 | 85 |
GO:00072652 | Colorectum | FAP | Ras protein signal transduction | 80/2622 | 337/18723 | 9.61e-07 | 4.33e-05 | 80 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ALB | SNV | Missense_Mutation | | c.23N>T | p.Ser8Phe | p.S8F | P02768 | protein_coding | tolerated(0.51) | possibly_damaging(0.59) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ALB | SNV | Missense_Mutation | rs74826639 | c.1585N>A | p.Glu529Lys | p.E529K | P02768 | protein_coding | tolerated(0.31) | benign(0.019) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
ALB | SNV | Missense_Mutation | | c.77N>G | p.Ala26Gly | p.A26G | P02768 | protein_coding | tolerated(0.06) | benign(0) | TCGA-22-5492-01 | Lung | lung squamous cell carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
ALB | SNV | Missense_Mutation | rs764279820 | c.314G>A | p.Arg105His | p.R105H | P02768 | protein_coding | tolerated(0.08) | possibly_damaging(0.731) | TCGA-34-2604-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ALB | SNV | Missense_Mutation | | c.949N>T | p.Val317Leu | p.V317L | P02768 | protein_coding | tolerated(0.43) | benign(0) | TCGA-37-3792-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ALB | SNV | Missense_Mutation | novel | c.361N>C | p.Glu121Gln | p.E121Q | P02768 | protein_coding | deleterious(0.01) | probably_damaging(0.966) | TCGA-43-8118-01 | Lung | lung squamous cell carcinoma | Female | <65 | I/II | Chemotherapy | docetaxel | SD |
ALB | SNV | Missense_Mutation | | c.508N>T | p.His170Tyr | p.H170Y | P02768 | protein_coding | deleterious(0.02) | possibly_damaging(0.763) | TCGA-46-3769-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | SD |
ALB | SNV | Missense_Mutation | novel | c.781N>T | p.Asp261Tyr | p.D261Y | P02768 | protein_coding | deleterious(0) | probably_damaging(0.988) | TCGA-56-7822-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Chemotherapy | eloxatin | PD |
ALB | SNV | Missense_Mutation | | c.129C>G | p.Phe43Leu | p.F43L | P02768 | protein_coding | deleterious(0) | possibly_damaging(0.828) | TCGA-56-A5DR-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ALB | SNV | Missense_Mutation | novel | c.523N>T | p.Ala175Ser | p.A175S | P02768 | protein_coding | tolerated(0.05) | benign(0.227) | TCGA-63-A5MW-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | Sodium lauryl sulfate | | |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | Gadofosveset | GADOFOSVESET | |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | RALTITREXED | RALTITREXED | 15025739 |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | Activated recombinant FVII-albumin fusion protein | | |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | Oxyphenbutazone | OXYPHENBUTAZONE | |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | EPIGALOCATECHIN GALLATE | EPIGALOCATECHIN GALLATE | 20598557 |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | PHENYLBUTAZONE | PHENYLBUTAZONE | 20869876 |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | EPIGALLOCATECHIN | EPIGALLOCATECHIN | 20598557 |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | Iodipamide | IODIPAMIDE | |
213 | ALB | TRANSPORTER, DRUGGABLE GENOME | | [19F]-HALOPERIDOL | [19F]-HALOPERIDOL | |